Karen Knudsen, Chief Executive Officer and Executive Director at Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:
“Great to hear Chris Klomp at The Wall Street Journal Future of Health discuss the imperative of HHS to expand access to clinical trials in the US.
Could not agree more – critical for access to the most advanced form of cancer care!”
Read more articles featuring Karen Knudsen on OncoDaily.